# An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US

> **NCT02783651** · — · COMPLETED · sponsor: **Amgen** · enrollment: 212 (actual)

## Conditions studied

- Relapsed/Refractory Acute Lymphoblastic Leukemia

## Interventions

- **OTHER:** Other

## Key facts

- **NCT ID:** NCT02783651
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-30
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 212 (ACTUAL)
- **Last updated:** 2020-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02783651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02783651, "An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02783651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*